Trial site
University Hospital of Patras
Pátrai, Achaḯa 26504, GreeceNot linked to an institution yet
- 12running trials
- 2closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Eli Lilly and Company5 trials
- University Hospital of Patras3 trials
- Aikaterini Karaivazoglou1 trial
- Centro per la Lotta Contro l'Infarto - Fondazione Onlus1 trial
- Dr. Konstantinos Katsanos1 trial
- and 3 more
Running trials
Not yet recruiting
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
NCT07505459· Aikaterini Karaivazoglou· Source
Contact: Aikaterini Karaivazoglou, PhD, Assistant Professor
Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336· Phase 3· Eli Lilly and Company· Source
Contact: Angelos Koutras (principal investigator)
Recruiting
Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications
NCT07186933· University General Hospital of Patras· Source
Contact: Diamanto Aretha, Associate Professor
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT06890598· Phase 3· Eli Lilly and Company· Source
Contact: Angelos Koutras (principal investigator)
Recruiting
Pressure (Fractional Flow Reserve) and Flow (Vascular Flow Reserve) Measurements During Peripheral Arterial Interventions
NCT07052435· Dr. Konstantinos Katsanos· Source
Contact: Konstantinos Katsanos, MSc, MD, PhD, EBIR
Recruiting
Correlation of Typical LBBB Mechanical Activation Pattern by 2D Strain Echocardiography With Acute GWE Improvement in Patients Receiving LBBp or Conventional BiVp for Cardiac Resynchronization Therapy (Echo LBBp)
NCT06689111· University Hospital of Patras· Source
Contact: Georgios Leventopoulos, MD, PhD
Recruiting
Southeastern Europe Microcirculation Registry
NCT06393478· Institute for Cardiovascular Diseases Dedinje· Source
Contact: Michail Papafaklis, MD, PhD
Recruiting
The AMARA (As Much As Reasonably Achievable) Study
NCT06257030· University Hospital of Patras· Source
Contact: Theoni Kaplanidou
Active, not recruiting
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT05288166· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
NCT05169567· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
NCT05027984· Centro per la Lotta Contro l'Infarto - Fondazione Onlus· Source
Active, not recruiting
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
NCT02107703· Phase 3· Eli Lilly and Company· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error